Literature DB >> 8289835

Two different sequence elements within exon 4 are necessary for calcitonin-specific splicing of the human calcitonin/calcitonin gene-related peptide I pre-mRNA.

C C van Oers1, G J Adema, H Zandberg, T C Moen, P D Baas.   

Abstract

The calcitonin (CT)/calcitonin gene-related peptide I (CGRP-I) gene (CALC-I gene) is subject to alternative tissue-specific processing of its primary transcript. CT mRNA is the predominant mRNA produced in thyroid C cells, whereas CT gene-related peptide I mRNA is the main product in neurons of the central and peripheral nervous systems. The CT-specific exon 4 is surrounded by weak processing sites. In this study we have investigated whether exon 4 sequences are involved in the tissue-specific selection of the exon 4 splice acceptor site. The results indicate that two separate elements, termed A and B, in the 5' part of exon 4 are required for production of CT-specific RNA. These sequences are located between nucleotides 67 and 88 (A) and nucleotides 117 and 146 (B) relative to the 5' end of exon 4. Variation of the distance between these sequence elements and the 3' splice site of exon 4 does not change the processing choice. These sequence elements are functionally equivalent. CT-specific splicing requires the presence of both sequence A and B or duplicates of either sequence element in exon 4. The effect of these sequences on the RNA processing choice is overruled by mutation of the CT-specific uridine branch acceptor nucleotide into a commonly preferred adenosine residue.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289835      PMCID: PMC358450          DOI: 10.1128/mcb.14.2.951-960.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

1.  Unexpected point mutations activate cryptic 3' splice sites by perturbing a natural secondary structure within a yeast intron.

Authors:  J O Deshler; J J Rossi
Journal:  Genes Dev       Date:  1991-07       Impact factor: 11.361

2.  Tissue-specific splicing in vivo of the beta-tropomyosin gene: dependence on an RNA secondary structure.

Authors:  D Libri; A Piseri; M Y Fiszman
Journal:  Science       Date:  1991-06-28       Impact factor: 47.728

3.  Validation of an in vitro RNA processing system for CT/CGRP precursor mRNA.

Authors:  G J Cote; I N Nguyen; C J Lips; S M Berget; R F Gagel
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

4.  Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing.

Authors:  J G Patton; S A Mayer; P Tempst; B Nadal-Ginard
Journal:  Genes Dev       Date:  1991-07       Impact factor: 11.361

5.  A role for exon sequences and splice-site proximity in splice-site selection.

Authors:  R Reed; T Maniatis
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

6.  Amount of RNA secondary structure required to induce an alternative splice.

Authors:  D Solnick; S I Lee
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

7.  Heterogeneous nuclear ribonucleoproteins: role in RNA splicing.

Authors:  Y D Choi; P J Grabowski; P A Sharp; G Dreyfuss
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

8.  Model for alternative RNA processing in human calcitonin gene expression.

Authors:  R A Bovenberg; W P van de Meerendonk; P D Baas; P H Steenbergh; C J Lips; H S Jansz
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

9.  Deregulation of alternative processing of Calcitonin/CGRP-I pre-mRNA by a single point mutation.

Authors:  G J Adema; P D Baas
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

10.  The role of exon sequences in splice site selection.

Authors:  A Watakabe; K Tanaka; Y Shimura
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

View more
  29 in total

1.  The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4.

Authors:  E Stickeler; S D Fraser; A Honig; A L Chen; S M Berget; T A Cooper
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

2.  Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.

Authors:  M J Simard; B Chabot
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

Review 3.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

4.  Role for Fox-1/Fox-2 in mediating the neuronal pathway of calcitonin/calcitonin gene-related peptide alternative RNA processing.

Authors:  Hua-Lin Zhou; Andrew P Baraniak; Hua Lou
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

5.  Repression of prespliceosome complex formation at two distinct steps by Fox-1/Fox-2 proteins.

Authors:  Hua-Lin Zhou; Hua Lou
Journal:  Mol Cell Biol       Date:  2008-06-23       Impact factor: 4.272

6.  Regulation of alternative polyadenylation by U1 snRNPs and SRp20.

Authors:  H Lou; K M Neugebauer; R F Gagel; S M Berget
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Three recognition events at the branch-site adenine.

Authors:  C C Query; S A Strobel; P A Sharp
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

8.  Base pairing at the 5' splice site with U1 small nuclear RNA promotes splicing of the upstream intron but may be dispensable for slicing of the downstream intron.

Authors:  D Y Hwang; J B Cohen
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  A short sequence within two purine-rich enhancers determines 5' splice site specificity.

Authors:  L L Elrick; M B Humphrey; T A Cooper; S M Berget
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

10.  Architectural limits on split genes.

Authors:  D A Sterner; T Carlo; S M Berget
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.